Delivery Order SPE2DB20D3101-SPE2DB25FRWU0
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for Ketorolac 30 mg/mL vials with a ceiling value of $2,472.26. This firm fixed-price delivery order represents a non-competitive set-aside contract and carries an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,163.76 to AmerisourceBergen Drug Corp for Ketorolac 30 mg/ml vials on August 28, 2025, with completion scheduled for August 29, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ketorolac is a nonsteroidal anti-inflammatory drug commonly used for pain management across military and federal healthcare systems....
- The Defense Logistics Agency awarded a $2,424.50 firm fixed price delivery order to AmerisourceBergen Drug Corp for Ketorolac 30 mg/ml vials. This delivery order was issued without a set-aside designation, indicating open competition, and carries an ultimate completion date of July 7, 2025. The award was issued on July 3, 2025, with performance to be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,427.96 to AmerisourceBergen Drug Corp for the supply of Ketorolac 30 mg/mL vials. This contract, awarded on August 28, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 29, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating it was competitively procured through open...
- The Defense Logistics Agency (DLA) awarded a $1,998.51 delivery order to AmerisourceBergen Drug Corp for Ketorolac 30 mg/ml vials on May 12, 2025, with completion targeted for May 13, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order under the company's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award carries no set-aside designation and will be performed at the contractor's Corporate Office location in...
- The Defense Logistics Agency awarded a $1,086.88 delivery order to AmerisourceBergen Drug Corp for Ketorolac 30 mg/ml vials under a firm fixed price contract type. The award was issued on July 11, 2025, with an ultimate completion date of July 14, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order is a child contract under...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $1,194.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Ketorolac 30 mg/ml vials. The contract is a non-set-aside competitive award with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of August 19, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Department's Medical Supply Chain has awarded a $6,176.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ketorolac 30 mg/mL vials. The contract was competitively awarded without set-aside provisions on August 18, 2025, with an ultimate completion date of August 19, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under...
- The Defense Logistics Agency awarded a $7,130.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Ketorolac 30 mg/ml vials. This non-set-aside contract is scheduled for completion by June 2, 2025, and represents a routine pharmaceutical procurement supporting federal medical supply needs. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,250.60 to AmerisourceBergen Drug Corp for Ketorolac 30 mg/ml vials, with completion scheduled for August 19, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement typical of pharmaceutical supply orders under the DLA's medical procurement framework. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRWU0Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,115.75 for Ketorolac 30 mg/ml vials, with an ultimate completion date of September 29, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a $999,999,999 ceiling value through December 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. Ketorolac is a nonsteroidal anti-inflammatory drug commonly used for moderate pain management in military and federal healthcare settings. This delivery order exemplifies the routine pharmaceutical procurement activities conducted through AmerisourceBergen's prime vendor contract with DLA, which enables the company to supply a comprehensive range of medications, vaccines, and medical supplies to support Defense Health Agency and military healthcare systems worldwide. AmerisourceBergen's established federal procurement track record and competitive positioning as a major pharmaceutical distributor demonstrates its capability to fulfill critical medical supply needs for the federal government across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/26/25 |